SLC2A1 and neoplasm: Apart from its tumor-targeting property toward the GLUT-overexpressingcancer cells, which is not present in the previously reported Pt(II)-BODIPYmetallo-supramolecular complexes, the compound exhibits high chemo-and photocytotoxicities against a range of cancer cell lines, includingthe cisplatin-resistant R-HepG2 cells